Strong demand for biologic hernia repair product to drive TSL (Tissue Science Laboratories) growth
This article was originally published in Clinica
Executive Summary
With the market for biological hernia repair products expected to grow at a rate of 30% to hit $300m by 2010, UK tissue implant developer Tissue Science Laboratories (TSL) has put in place the springboard to capitalise on this growth.